A serum-based DNA methylation assay provides accurate detection of glioma (2021)
- Authors:
- Sabedot, Thais S
- Malta, Tathiane M
- Snyder, James
- Nelson, Kevin
- Wells, Michael
- Carvalho, Ana C. de
- Mukherjee, Abir
- Chitale, Dhananjay A
- Mosella, Maritza S
- Sokolov, Artem - Harvard University (HU)
- Asmaro, Karam P
- Robin, Adam
- Rosenblum, Mark L
- Mikkelsen, Tom
- Rock, Jack
- Poisson, Laila M
- Lee, Ian
- Walbert, Tobias
- Kalkanis, Steven
- Iavarone, Antonio - Columbia University (CU)
- Castro, Ana Valeria
- Noushmehr, Houtan
- Autor USP: NOUSHMEHR, HOUTAN - FMRP
- Unidade: FMRP
- DOI: 10.1093/neuonc/noab023
- Subjects: BIOMARCADORES; GLIOMA; NEOPLASIAS CEREBRAIS; METILAÇÃO DE DNA; EPIGÊNESE GENÉTICA; BIÓPSIA
- Keywords: Cell-free DNA; Epigenetics; Glioma; Pseudoprogression; Serum
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Neuro-Oncology
- ISSN: 1522-8517
- Volume/Número/Paginação/Ano: v. 23, n. 9, p. 1494-1508, 2021
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
-
ABNT
SABEDOT, Thais S et al. A serum-based DNA methylation assay provides accurate detection of glioma. Neuro-Oncology, v. 23, n. 9, p. 1494-1508, 2021Tradução . . Disponível em: https://doi.org/10.1093/neuonc/noab023. Acesso em: 24 abr. 2024. -
APA
Sabedot, T. S., Malta, T. M., Snyder, J., Nelson, K., Wells, M., Carvalho, A. C. de, et al. (2021). A serum-based DNA methylation assay provides accurate detection of glioma. Neuro-Oncology, 23( 9), 1494-1508. doi:10.1093/neuonc/noab023 -
NLM
Sabedot TS, Malta TM, Snyder J, Nelson K, Wells M, Carvalho AC de, Mukherjee A, Chitale DA, Mosella MS, Sokolov A, Asmaro KP, Robin A, Rosenblum ML, Mikkelsen T, Rock J, Poisson LM, Lee I, Walbert T, Kalkanis S, Iavarone A, Castro AV, Noushmehr H. A serum-based DNA methylation assay provides accurate detection of glioma [Internet]. Neuro-Oncology. 2021 ; 23( 9): 1494-1508.[citado 2024 abr. 24 ] Available from: https://doi.org/10.1093/neuonc/noab023 -
Vancouver
Sabedot TS, Malta TM, Snyder J, Nelson K, Wells M, Carvalho AC de, Mukherjee A, Chitale DA, Mosella MS, Sokolov A, Asmaro KP, Robin A, Rosenblum ML, Mikkelsen T, Rock J, Poisson LM, Lee I, Walbert T, Kalkanis S, Iavarone A, Castro AV, Noushmehr H. A serum-based DNA methylation assay provides accurate detection of glioma [Internet]. Neuro-Oncology. 2021 ; 23( 9): 1494-1508.[citado 2024 abr. 24 ] Available from: https://doi.org/10.1093/neuonc/noab023 - Charting epigenomic signatures in CpG island methylator phenotype (CIMP) tumors
- Whole genome DNA is distinctly methylated in functioning and non-functioning pituitary macroadenomas
- The functionality of prostate cancer predisposition risk regions is revealed by AR enhancers
- Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31
- The cancer genome atlas pan-cancer analysis project
- Genome-wide fingerprinting of regulatory chromatin to evaluate the tissue specific origins of high-grade serous ovarian cancer
- Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin
- Src as a novel therapeutic target for endometriosis
- Prognostic significance of epigenetic subtypes and CPGS associated with progression to G-CIMP low in the eortc randomized phase III intergroup catnon
- Methylation-based liquid biopsy of meningioma primary and recurrent samples
Informações sobre o DOI: 10.1093/neuonc/noab023 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
